company background image
43E0 logo

electroCore DB:43E0 Stock Report

Last Price

€3.67

Market Cap

€29.2m

7D

0%

1Y

-15.3%

Updated

16 May, 2023

Data

Company Financials +

43E0 Stock Overview

A commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. More details

43E0 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

electroCore, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for electroCore
Historical stock prices
Current Share PriceUS$3.67
52 Week HighUS$9.96
52 Week LowUS$2.50
Beta1.21
1 Month Change0%
3 Month Change-13.44%
1 Year Change-15.30%
3 Year Change-70.37%
5 Year Changen/a
Change since IPO-97.98%

Recent News & Updates

Recent updates

Shareholder Returns

43E0DE Medical EquipmentDE Market
7D0%0.9%1.3%
1Y-15.3%-9.7%9.0%

Return vs Industry: 43E0 underperformed the German Medical Equipment industry which returned -2.5% over the past year.

Return vs Market: 43E0 underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 43E0's price volatile compared to industry and market?
43E0 volatility
43E0 Average Weekly Movementn/a
Medical Equipment Industry Average Movement6.6%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 43E0's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine 43E0's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200562Dan Goldbergerwww.electrocore.com

electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM, a form of nVNS for human performance. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years.

electroCore, Inc. Fundamentals Summary

How do electroCore's earnings and revenue compare to its market cap?
43E0 fundamental statistics
Market cap€29.25m
Earnings (TTM)-€20.66m
Revenue (TTM)€8.72m

3.4x

P/S Ratio

-1.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
43E0 income statement (TTM)
RevenueUS$9.47m
Cost of RevenueUS$1.48m
Gross ProfitUS$8.00m
Other ExpensesUS$30.45m
Earnings-US$22.45m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-4.73
Gross Margin84.43%
Net Profit Margin-236.96%
Debt/Equity Ratio0%

How did 43E0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/05/16 07:34
End of Day Share Price 2023/02/16 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

electroCore, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverBrookline Capital Markets
Tyler BussianBrookline Capital Markets
Sean LavinBTIG